RFL

Rafael Holdings, Inc.

1.81 USD
+0.02 (+1.12%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Rafael Holdings, Inc. stock is up 2.84% since 30 days ago. The next earnings date is Dec 22, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 December’s closed higher than November.

About Rafael Holdings, Inc.

Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies and commercial real estate assets. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.